DURECT Corporation Operating Income

Operating Income of DRRX for past 10 years: annual, quarterly and twelve month trailing (TTM) including Operating Income growth rates and interactive chart. Operating income is the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation, and cost of goods sold (COGS). Operating income–also called income from operations–takes a company's gross income, which is equivalent to total revenue minus COGS, and subtracts all operating expenses. A business's operating expenses are costs incurred from normal operating activities and include items such as office supplies and utilities. Operating income is measured before interest and tax expenses and is a good gauge of a company's operational profitability.

Highlights and Quick Summary

  • Operating Income for the quarter ending June 30, 2023 was $-10.1 Million (a -8.81% decrease compared to previous quarter)
  • Year-over-year quarterly Operating Income increased by 371.44%
  • Annual Operating Income for 2022 was $-35.1 Million (a 2.36% increase from previous year)
  • Annual Operating Income for 2021 was $-34.3 Million (a 171.68% increase from previous year)
  • Annual Operating Income for 2020 was $-12.6 Million (a -36.75% decrease from previous year)
  • Twelve month Operating Income ending June 30, 2023 was $-34.7 Million (a -2.9% decrease compared to previous quarter)
  • Twelve month trailing Operating Income increased by 15.31% year-over-year
Trailing Operating Income for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
$-34.7 Million $-35.7 Million $-35.1 Million $-30.1 Million
Visit stockrow.com/DRRX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Operating Income of DURECT Corporation

Most recent Operating Incomeof DRRX including historical data for past 10 years.

Interactive Chart of Operating Income of DURECT Corporation

DURECT Corporation Operating Income for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-10.05 $-11.02 – – –
2022 $-11.5 $-2.13 $-11.09 $-10.37 $-35.08
2021 $-6.51 $-9.46 $-8.66 $-9.65 $-34.27
2020 $-8.31 $-8.83 $14.34 $-9.82 $-12.62
2019 $-4.47 $-1.71 $-6.77 $-6.71 $-19.94
2018 $-6.91 $-2.29 $-6.61 $-7.83 $-23.64
2017 $8.57 $6.13 $-9.37 $-7.57 $-2.24
2016 $-8.26 $-8.29 $-8.5 $-7.32 $-32.36
2015 $-5.33 $-5.97 $-4.94 $-4.42 $-20.66
2014 $-5.36 $-6.59 $-5.45 $-3.6 $-21.0
2013 $-5.09 $-5.72 $-5.16 $-5.2 $-21.16
2012 $-5.59 $-4.81 – – $16.06

Business Profile of DURECT Corporation

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic
© stockrow.com